Bruker Granted FDA Clearance to Market the MALDI Biotyper CA System

News   Nov 26, 2013

 
Bruker Granted FDA Clearance to Market the MALDI Biotyper CA System
 
 
 

RELATED ARTICLES

Stable Beta-Amyloid Dimers Identified in Alzheimer’s Brains

News

A recent study exploited state-of-the-art mass spectrometry to provide the first direct evidence of beta-amyloid dimers in patients with Alzheimer’s disease and points to the potential of these molecules as biomarkers. Beta-amyloid dimers may be the smallest pathological species that trigger Alzheimer’s disease.

READ MORE

Detecting Heart Disease with an AI App

News

The process of assessing and monitoring heart disease, the leading cause of death in the US, is often expensive and time-consuming. A new app that incorporates pulse data to diagnose arterial changes could simplify the whole process.

READ MORE

New Rapid-fire Method Using Pathology Images & Tumor Data May Help Guide Cancer Therapies

News

By combining data on pathology images of 13 types of cancer and correlating that with clinical and genomic data, researchers are able to identify tumor-infiltrating lymphocytes, which will enable cancer specialists to generate tumor-immune information from routinely gathered pathology slides.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE